Cendrowski, W. (2010). Interferon beta and glatiramer acetate modify over two decades the course of relapsing-remitting multiple sclerosis?. European Journal of Clinical and Experimental Medicine, 8(3), 330–337. Retrieved from https://journals.ur.edu.pl/ejcem/article/view/13041